BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs2476601
,
PDX1
,
Response to oxidative stress
,
Influenza
,
Prostate
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
imatinib mesylate
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CYP1A1
LCN2
EGR1
DUSP6
TF
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
heterocyclic compound binding
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
organic cyclic compound metabolic process
PILON_KLF1_TARGETS_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Pre-B cells double-stranded breaks (DSBs) induced not repaired
Explore Curated Studies Results
Literature
Most Relevant Literature
Lichenoid drug eruption associated with imatinib mesylate therapy.
Effect of Imatinib Mesylate on Growth in Pediatric Chronic Myeloid Leukemia: A Systematic Review and…
Imatinib-induced eruptive nevi.
An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis.
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adver…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stro…
Ipilimumab and Imatinib Mesylate in Advanced Cancer
A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ